Want to join the conversation?
$BAX, which competes with $COV and $CAH, said in 2015 the company recognized approx. $40MM in government sales for ProtoCAM. Given the purchasing pattern of this product, the company does not anticipate any sales in 2016 in Integrated Pharmacy Solutions (IPS). In surgical care franchise sales is expected to grow 2-3%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.